Trials / Unknown
UnknownNCT04468477
EVALECGcardio Study
An Evaluation of the Safety and Clinical Utility of Handheld ECG Technology in Cardiology
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 750 (estimated)
- Sponsor
- The Leeds Teaching Hospitals NHS Trust · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
ECGs are routinely performed in cardiology. Recently handheld ECGs have shown promise in screening for heart rhythm disorders. These are quick to perform and do not require the preparation that is needed for 12 lead ECGs. We wanted to test whether a novel handheld ECG recorder, Kardia 6L, which has the potential to record a 6 lead ECG is able to screen for ECG abnormalities, thereby obviating the need for a full 12 lead ECG. This may allow for earlier diagnosis and treatment.
Detailed description
The aim of analysis is to determine if the handheld 6 lead ECG can be used as a simple screener to identify patients who do not need a 12 lead ECG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 6 Lead ECG | Patients will be assessed with the Kardiamobile device. |
Timeline
- Start date
- 2020-05-29
- Primary completion
- 2021-05-21
- Completion
- 2021-05-21
- First posted
- 2020-07-13
- Last updated
- 2020-07-13
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04468477. Inclusion in this directory is not an endorsement.